VF
SCPS

Virtu Financial’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Virtu Financial’s Portfolio SCPS Stock Details SCPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,229
Closed -$21K – 2324
2022
Q1 		$21K Buy
30,229
+15,198
+101% +$14.7K ﹤0.01% 1292
2021
Q4 		$25K Buy
+15,031
New +$45.6K ﹤0.01% 1489
2021
Q1 		– Sell
-16,280
Closed -$242K – 2230
2020
Q4 		$242K Buy
+16,280
New +$288K 0.03% 757

Other funds holding SCPS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MRCM
M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial's SCPS Position: Q2 2022 in Review

Virtu Financial sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q2 2022, closing a stake of 30,229 shares — an estimated $21K sold.

Virtu Financial first reported a position in SCPS in Q4 2020 and held it in 3 quarters. The position peaked at $242K in Q4 2020. 17 funds tracked by Wall St. Rank hold SCPS as of Q2 2022.

  • Virtu Financial reported no remaining Scopus BioPharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Virtu Financial sold 30,229 Scopus BioPharma Inc. Common Stock shares in Q2 2022, an estimated $21K.
  • Virtu Financial first reported a position in Scopus BioPharma Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Virtu Financial's Scopus BioPharma Inc. Common Stock position peaked at $242K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.